Symbol="CNTB"
AssetType="Common Stock"
Name="Connect Biopharma Holdings Ltd"
Description="Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, is focused on the discovery and development of immune modulators for the treatment of severe autoimmune diseases and inflammation. The company is headquartered in Taicang, China."
CIK="1835268"
Exchange="NASDAQ"
Currency="USD"
Country="China"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="SCIENCE & TECH PARK, EAST R&D BLDG, 3 FL, EAST R&D BUILDING, 3RD FLOOR, 6 BEIJING WEST ROAD, TAICANG, CHINA"
FiscalYearEnd="December"
LatestQuarter="2022-06-30"
MarketCapitalization="50638000"
EBITDA="-780296000"
PERatio="None"
PEGRatio="None"
BookValue="19.93"
DividendPerShare="0"
DividendYield="0"
EPS="-2.02"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.32"
ReturnOnEquityTTM="-0.563"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.02"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="6.33"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.194"
EVToRevenue="-"
EVToEBITDA="0.189"
Beta="-0.445"
num_52WeekHigh="1.69"
num_52WeekLow="0.62"
num_50DayMovingAverage="1.075"
num_200DayMovingAverage="1.016"
SharesOutstanding="55041000"
DividendDate="None"
ExDividendDate="None"
symbol="CNTB"
open="0.93"
high="0.94"
low="0.92"
price="0.92"
volume="2067.00"
latest_trading_day="2023-08-14"
previous_close="0.92"
change="0.00"
change_percent="0.0000%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="69"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="31"
Volume_recent_avg="256656"
Change_recent_avg="0.01"
Delta_recent_avg="0.1"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="-0.36"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="31"
Aroon_momentum_negative="69"
image_negative_thumbnail_id_1="1145"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0178.jpeg"
image_negative_thumbnail_id_2="499"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0106.jpeg"
image_neutral_thumbnail_id_1="549"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0050.jpeg"
image_neutral_thumbnail_id_2="591"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0008.jpeg"
image_positive_thumbnail_id_1="959"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0121.jpeg"
image_positive_thumbnail_id_2="977"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0139.jpeg"
image_professor_thumbnail_id_1="1200"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0034.jpeg"
image_professor_thumbnail_id_2="1194"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
